Tatvartha Health Private Limited, operating as Traya, secured a Series B investment from Xponentia Opportunities Fund II, giving the fund a 6.68% stake for approximately INR 75 crore. Cyril Amarchand Mangaldas (CAM) provided legal counsel to Traya and its promoters throughout the transaction, navigating the complexities of the capital infusion.
The deal involved notable players, with existing investors Fireside Ventures Investment Fund II, Whiteboard Capital Fund I, Beacon Trusteeship Limited, and Kae Capital Fund III participating. The transaction saw CAM’s Dhruv Singhal leading the charge, supported by a team of legal experts, including Aparna Menon, Hina Tolani, Shivangini Singh, Bhavya Arya, and Rushil Mehta.
Key documentation was finalized on March 27, 2024, with the deal closing swiftly the next day. This investment marks another step in Traya’s growth journey, leveraging expertise across healthcare and venture ecosystems.
